Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$231,318
-$129,765 QoQ
Shares Held
1,476
-54.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,254
of 1,603 holders
Holding Since
Mar 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$1,959,000
PutShares
12,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SIG BROKERAGE, LP holds $21,389,610 across 9 Drug Manufacturers - General names. NVS ranks #9 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
67,374 | $8,657,559 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
52,809 | $6,671,889 | |
| 3 | LLY |
ELI LILLY & Co
|
1,487 | $1,783,552 | |
| 4 | BIIB |
Biogen Inc.
|
6,824 | $1,474,393 | |
| 5 | PFE |
Pfizer Inc
|
52,022 | $1,252,689 | |
| 6 | JNJ |
Johnson & Johnson
|
2,095 | $532,067 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,817 | $508,035 | |
| 8 | AMGN |
Amgen Inc
|
768 | $278,108 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $231,318 | 1,476 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $1,959,000 | 12,500 | Put | Sole | 2026-08-14 | |
| 2025-03-31 | $361,083 | 3,239 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||